註冊登入

主页
医学图书S馆
医学图书M馆
医学图书D馆
医学术语
群组
活动
用户工具
推广

search

MeSH 搜索器

Inotuzumab Ozogamicin

Immunotoxin that consists of anti-CD22 (CD22 ANTIGEN) humanized monoclonal antibody covalently linked to the antineoplastic antibiotic CALICHEAMICIN. It is used for the treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (LEUKEMIA, ACUTE LYMPHOBLASTIC).

推出的年份: 2020(2004)

副标题

administration and dosage

adverse effects

analysis

blood

cerebrospinal fluid

chemistry

classification

drug effects

economics

genetics

history

immunology

isolation and purification

metabolism

pharmacokinetics

pharmacology

poisoning

radiation effects

therapeutic use

toxicity

ultrastructure

urine

树号: D09.408.051.247.750, D12.776.124.486.485.114.224.060.794, D12.776.124.790.651.114.224.060.794, D12.776.377.715.548.114.224.200.794

MeSH 单一 ID: D000080045

进入的组:

Besponsa
CMC544
CMC-544
CMC 544

药理作用*:

Antineoplastic Agents, Immunological
Antibiotics, Antineoplastic
Immunotoxins

All MeSH Categories
- Chemicals and Drugs Category
  - Carbohydrates [D09]
    - Glycosides [D09.408]
      - Aminoglycosides [D09.408.051]
        
        Calicheamicins [D09.408.051.247]
        
        Gemtuzumab [D09.408.051.247.500]
        
        Inotuzumab Ozogamicin [D09.408.051.247.750]

All MeSH Categories
- Chemicals and Drugs Category
  - Amino Acids, Peptides, and Proteins [D12]
    - Proteins [D12.776]
      - Blood Proteins [D12.776.124]
        
        Immunoproteins [D12.776.124.486]
        
        Immunoglobulins [D12.776.124.486.485]
        
        Antibodies [D12.776.124.486.485.114]
        
        Antibodies, Monoclonal [D12.776.124.486.485.114.224]
        
        Antibodies, Monoclonal, Humanized [D12.776.124.486.485.114.224.060]
        
        Abciximab [D12.776.124.486.485.114.224.060.125]
        
        Adalimumab [D12.776.124.486.485.114.224.060.250]
        
        Alemtuzumab [D12.776.124.486.485.114.224.060.313]
        
        Basiliximab [D12.776.124.486.485.114.224.060.344]
        
        Bevacizumab [D12.776.124.486.485.114.224.060.375]
        
        Brentuximab Vedotin [D12.776.124.486.485.114.224.060.438]
        
        Certolizumab Pegol [D12.776.124.486.485.114.224.060.500]
        
        Cetuximab [D12.776.124.486.485.114.224.060.750]
        
        Daclizumab [D12.776.124.486.485.114.224.060.766]
        
        Denosumab [D12.776.124.486.485.114.224.060.782]
        
        Gemtuzumab [D12.776.124.486.485.114.224.060.790]
        
        Inotuzumab Ozogamicin [D12.776.124.486.485.114.224.060.794]
        
        Ipilimumab [D12.776.124.486.485.114.224.060.798]
        
        Natalizumab [D12.776.124.486.485.114.224.060.813]
        
        Nivolumab [D12.776.124.486.485.114.224.060.829]
        
        Omalizumab [D12.776.124.486.485.114.224.060.844]
        
        Palivizumab [D12.776.124.486.485.114.224.060.860]
        
        Panitumumab [D12.776.124.486.485.114.224.060.864]
        
        Ranibizumab [D12.776.124.486.485.114.224.060.868]
        
        Trastuzumab [D12.776.124.486.485.114.224.060.875] add_circle
        
        Ustekinumab [D12.776.124.486.485.114.224.060.937]

All MeSH Categories
- Chemicals and Drugs Category
  - Amino Acids, Peptides, and Proteins [D12]
    - Proteins [D12.776]
      - Blood Proteins [D12.776.124]
        
        Serum Globulins [D12.776.124.790]
        
        Immunoglobulins [D12.776.124.790.651]
        
        Antibodies [D12.776.124.790.651.114]
        
        Antibodies, Monoclonal [D12.776.124.790.651.114.224]
        
        Antibodies, Monoclonal, Humanized [D12.776.124.790.651.114.224.060]
        
        Abciximab [D12.776.124.790.651.114.224.060.125]
        
        Adalimumab [D12.776.124.790.651.114.224.060.250]
        
        Alemtuzumab [D12.776.124.790.651.114.224.060.375]
        
        Basiliximab [D12.776.124.790.651.114.224.060.407]
        
        Bevacizumab [D12.776.124.790.651.114.224.060.438]
        
        Brentuximab Vedotin [D12.776.124.790.651.114.224.060.469]
        
        Certolizumab Pegol [D12.776.124.790.651.114.224.060.500]
        
        Cetuximab [D12.776.124.790.651.114.224.060.750]
        
        Daclizumab [D12.776.124.790.651.114.224.060.766]
        
        Denosumab [D12.776.124.790.651.114.224.060.782]
        
        Gemtuzumab [D12.776.124.790.651.114.224.060.790]
        
        Inotuzumab Ozogamicin [D12.776.124.790.651.114.224.060.794]
        
        Ipilimumab [D12.776.124.790.651.114.224.060.798]
        
        Natalizumab [D12.776.124.790.651.114.224.060.813]
        
        Nivolumab [D12.776.124.790.651.114.224.060.829]
        
        Omalizumab [D12.776.124.790.651.114.224.060.844]
        
        Palivizumab [D12.776.124.790.651.114.224.060.860]
        
        Panitumumab [D12.776.124.790.651.114.224.060.864]
        
        Ranibizumab [D12.776.124.790.651.114.224.060.868]
        
        Trastuzumab [D12.776.124.790.651.114.224.060.875] add_circle
        
        Ustekinumab [D12.776.124.790.651.114.224.060.937]

All MeSH Categories
- Chemicals and Drugs Category
  - Amino Acids, Peptides, and Proteins [D12]
    - Proteins [D12.776]
      - Globulins [D12.776.377]
        
        Serum Globulins [D12.776.377.715]
        
        Immunoglobulins [D12.776.377.715.548]
        
        Antibodies [D12.776.377.715.548.114]
        
        Antibodies, Monoclonal [D12.776.377.715.548.114.224]
        
        Antibodies, Monoclonal, Humanized [D12.776.377.715.548.114.224.200]
        
        Abciximab [D12.776.377.715.548.114.224.200.125]
        
        Adalimumab [D12.776.377.715.548.114.224.200.250]
        
        Alemtuzumab [D12.776.377.715.548.114.224.200.375]
        
        Basiliximab [D12.776.377.715.548.114.224.200.407]
        
        Bevacizumab [D12.776.377.715.548.114.224.200.438]
        
        Brentuximab Vedotin [D12.776.377.715.548.114.224.200.469]
        
        Certolizumab Pegol [D12.776.377.715.548.114.224.200.500]
        
        Cetuximab [D12.776.377.715.548.114.224.200.750]
        
        Daclizumab [D12.776.377.715.548.114.224.200.766]
        
        Denosumab [D12.776.377.715.548.114.224.200.782]
        
        Gemtuzumab [D12.776.377.715.548.114.224.200.790]
        
        Inotuzumab Ozogamicin [D12.776.377.715.548.114.224.200.794]
        
        Ipilimumab [D12.776.377.715.548.114.224.200.798]
        
        Natalizumab [D12.776.377.715.548.114.224.200.813]
        
        Nivolumab [D12.776.377.715.548.114.224.200.829]
        
        Omalizumab [D12.776.377.715.548.114.224.200.844]
        
        Palivizumab [D12.776.377.715.548.114.224.200.860]
        
        Panitumumab [D12.776.377.715.548.114.224.200.864]
        
        Ranibizumab [D12.776.377.715.548.114.224.200.868]
        
        Trastuzumab [D12.776.377.715.548.114.224.200.875] add_circle
        
        Ustekinumab [D12.776.377.715.548.114.224.200.937]

0 0 0 0 0 0 0

留言 (0)

登入或註冊以發表你的留言

Modal title

Modal title

关于我们
服务条款
隐私条款
联系我们
帮你推广
反馈

English
中文

Copyright © 2024 CN1699 Social. All rights reserved 中文

分享

登入

Global News and Health Forum
Join Now!

馬上登入

記住我

忘記密碼?

或者使用